Related Experiment Video
Updated: Jul 2, 2026

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
Published on: October 19, 2014
Crystal-Storing Histiocytosis as a Red Herring in Multiple Myeloma
Avik Basu1, Asish Rath1, Sushant Vinarkar2
1Department of Laboratory Hematology, Tata Medical Center, 14 Main Arterial Road (EW), Newtown, Rajarhat, Kolkata, 700156 India.
Abstract:
Multiple myeloma (MM) is a clonal plasma cell disorder characterized by aberrant immunoglobulin deposition causing end-organ damage (Jones et al. in Hum Pathol 30:1441-1448, 1999). Rarely, paraproteins crystallize within histiocytes, resulting in crystal-storing histiocytosis (CSH) (Jones et al. in Hum Pathol 30:1441-1448, 1999). The coexistence of MM, CSH, and amyloidosis is exceedingly uncommon (Takahashi et al. in Pathol Int 37:141-154, 1987). A 56-year-old male presented with chronic low back pain and elevated creatinine (~ 2.05 mg/dL). Myeloma workup revealed elevated beta-2 microglobulin (8.34 mg/L), an M-band (~ 1.75 g/dL), an abnormal free light chain ratio (~ 31.28), and increased IgG (~ 3272 mg/dL). Peripheral blood smear showed rouleaux formation. Bone marrow aspirate demonstrated 8% plasma cells and histiocytes with cytoplasmic crystals (Fig. 1A-C) Biopsy and immunohistochemistry confirmed CD138+interstitial plasma cell clusters (20-25%) and sheets of CD68+/CD163+crystal-laden histiocytes (Fig. 1D-L). Congo red-positive amyloid deposits were detected in blood vessels (Fig. 1M, N). This case highlights a rare triad of pathologies arising from paraprotein dyscrasia. This case underscores the significance of recognizing masquerading features such as CSH, which can result in an underestimation of plasma cells. The Patient was started on bortezomib based chemotherapy and is in very good partial response (VGPR) post 3-cycles of therapy.Fig. 1A-N Morphological and immunohistochemical features in myeloma with CSH. A BMA showing small mature plasma cells(Red arrow)(MGG 60x); B, C BMA showing histiocytes with foamy cytoplasm and intracytoplasmic grey blue crystals(white arrows) and scattered plasma cells (red arrows) (B;MGG 100x,C;MGG 60x) D BMBx showing sheets of histiocytes (H & E, 10x); E Eosinophilic Crystal laden histiocytes (H&E, 40x) and F clusters of plasma cells (H&E, 40x); G CD138 positive plasma cell aggregates (IHC, 10x); H cytoplasmic Kappa light chain positive in plasma cells (IHC, 10x); I Lambda light chain negative(IHC, 10x); J CD163 positive histiocytes in sheets (IHC, 10x); K CD68 positive histiocytes (IHC, 10x); L S-100 negative (IHC, 10x). M BMBX showing extracellular eosinophilic deposits (Congo red, 10x); N Eosinophilic deposits showing apple green birefringe under polarized light (10x). BMA bone marrow aspirate; BMBx bone marrow biopsy; H&E hematoxylin & eosin; CD cluster of differentiation; IHC immunohistochemistry.
Insights
This case report details an extremely rare instance of multiple myeloma (MM) coexisting with crystal-storing histiocytosis (CSH) and amyloidosis in a single patient. Recognizing CSH is crucial as it can mask underlying plasma cell disorders.
Area of Science:
- Hematology
- Oncology
- Pathology
Background:
- Multiple myeloma (MM) is a plasma cell disorder causing organ damage via immunoglobulin deposition.
- Crystal-storing histiocytosis (CSH) is a rare condition where paraproteins crystallize within histiocytes.
- The simultaneous occurrence of MM, CSH, and amyloidosis is exceptionally uncommon.
Purpose of the Study:
- To report a unique case of a 56-year-old male with the rare triad of MM, CSH, and amyloidosis.
- To highlight the diagnostic challenges posed by CSH, which can obscure the underlying plasma cell neoplasm.
- To emphasize the importance of comprehensive evaluation in patients with suspected paraprotein dyscrasias.
Main Methods:
- Clinical presentation of a patient with chronic low back pain and elevated creatinine.
- Laboratory investigations including M-band, free light chain ratio, and immunoglobulin levels.
- Bone marrow aspirate and biopsy with morphological examination, immunohistochemistry (CD138, CD68, CD163, S-100), and Congo red staining for amyloid detection.
Main Results:
- The patient presented with symptoms and laboratory findings consistent with MM.
- Bone marrow examination revealed plasma cells and histiocytes containing cytoplasmic crystals (CSH).
- Amyloid deposits were identified in blood vessels, confirming amyloidosis. The patient achieved very good partial response (VGPR) with bortezomib-based chemotherapy.
Conclusions:
- This case underscores the diagnostic significance of CSH, which can mimic other conditions and lead to underestimation of plasma cell burden.
- The co-presentation of MM, CSH, and amyloidosis represents a rare but critical diagnostic challenge in hematologic pathology.
- Early recognition and appropriate chemotherapy are vital for managing this complex paraprotein-related disorder.
More Related Videos
05:32Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
Published on: January 7, 2019
07:53Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma
Published on: April 15, 2022